Literature DB >> 9030863

Human autoimmune anti-proteinase 3 scFv from a phage display library.

R Finnern1, E Pedrollo, I Fisch, J Wieslander, J D Marks, C M Lockwood, W H Ouwehand.   

Abstract

This is the first study describing recombinant human antibody fragments directed to the autoantigen proteinase 3 (PR3) from an immune B cell source. Detection of these autoantibodies has proven valid for the diagnosis and monitoring of Wegener's granulomatosis. The described antibody fragment (scFv) was isolated from a phage display library prepared from the IgG-positive splenic lymphocytes of a patient with systemic autoimmunity. The cloning strategy was designed to maintain the diversity of the antibody variable gene repertoire, and sequencing of several variable genes demonstrated that all major heavy and light chain families were represented. We found an over-representation of particular heavy chain variable domains in splenic lymphocytes which differ from the ones frequently found in peripheral blood lymphocytes. It was possible to obtain specific scFv to PR3 after a single round of selection and the binding could be inhibited by the patients' sera. Although the antibody fragments in the splenic repertoire were found to be highly mutated, it was interesting to find that the selected scFv showed only limited somatic mutation. Furthermore, we could demonstrate that the removal of the mutations had no effect on binding specificity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030863      PMCID: PMC1904567          DOI: 10.1111/j.1365-2249.1997.254-ce1127.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

Review 1.  Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

2.  Two neutralizing human anti-RSV antibodies: cloning, expression, and characterization.

Authors:  C Heard; P Brams; E Walsh; T Huynh; S Chamat; M Reff; A Owyang; W Shestowsky; R Newman
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

3.  Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens.

Authors:  Nicole Reiche; Andreas Jung; Thomas Brabletz; Tanja Vater; Thomas Kirchner; Gerhard Faller
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin.

Authors:  Siham Chahboun; Michael Hust; Yvonne Liu; Thibaut Pelat; Sebastian Miethe; Saskia Helmsing; Russell Ga Jones; Dorothea Sesardic; Philippe Thullier
Journal:  BMC Biotechnol       Date:  2011-11-23       Impact factor: 2.563

5.  A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties.

Authors:  Felix Unverdorben; Meike Hutt; Oliver Seifert; Roland E Kontermann
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

Review 6.  Antibody Engineering for Pursuing a Healthier Future.

Authors:  Abdullah F U H Saeed; Rongzhi Wang; Sumei Ling; Shihua Wang
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

7.  Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

Authors:  Leticia L Niborski; Mariana Potenza; Renato G S Chirivi; Leandro Simonetti; Micaela S Ossowski; Vanina Grippo; Maria May; Daniela I Staquicini; Adriana Parodi-Talice; Carlos Robello; Marcelo A Comini; Guillermo D Alonso; Jos M H Raats; Karina A Gómez
Journal:  EBioMedicine       Date:  2021-01-08       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.